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Protozoan parasites of phylum Apicomplexa 
(for example, Plasmodium, Toxoplasma, Eimeria, 
and Cryptosporidium) represent important hu-
man and veterinary pathogens worldwide (1, 
2). Apicomplexans actively invade host cells 
and form parasitophorous vacuoles (PVs), 
which appear to be secluded from the endo-
cytic and lysosomal compartments of the in-
fected cell (3, 4). Nevertheless, the PV appears 
to provide an interface through which the par-
asite acquires nutrients from the host cytosol 
for growth and replication and alters innate im-
mune signaling (5, 6). The formation of a non-
fusogenic PV has been classically viewed as an 
adaptive mechanism for intracellular survival 
by apicomplexan parasites, allowing parasite 
evasion of lysosomal destruction. The immune 
response to several apicomplexans is character-
ized by the development of Th1 responses, in-
cluding the secretion of IFN-γ and TNF-α. In 
the case of Toxoplasma gondii infection, cell-au-
tonomous IFN-γ signaling of hemopoietic and 
nonhemopoietic cells is critical for immunity 
(7). Although IFN-γ–induced mechanisms 
(e.g., NO generation by type II NOS [8] and 
tryptophan degradation by IDO [9]) restricting 
parasite growth have been described, whether 
cytokine-activated cells can directly destroy 
Toxoplasma tachyzoites remains uncertain. In 
this study, we investigated the fate of tachyzo-
ites invading in vivo–primed macrophages. 
Our in-depth analysis revealed a novel and 
  sophisticated series of intracellular mechanisms 
used by macrophage eff  ector cells to destroy 
nonfusogenic intracellular parasites.
RESULTS AND DISCUSSION
We designed an experimental system using 
mice primed with a uracil-auxotrophic car-
bamoyl phosphate synthase null (CPS) strain 
(Fig. S1 A, available at http://www.jem.org/cgi/
content/full/jem.20061318/DC1; reference 10) 
that   allowed us to trace the fate of GFP-labeled 
T. gondii after entry into IFN-γ–activated host cells 
in vivo. At day 7 after priming, when peritoneal 
cells express the IFN-γ–inducible GTPase 
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IGTP (Fig. S1 B), we challenged the mice i.p. with GFP-
PTG, a low-virulence type II strain of T. gondii, and moni-
tored infection rate in peritoneal macrophages  (large, granular 
cells that are mostly CD11b+F4/80+), considered the pri-
mary eff  ector cells against T. gondii (11). Infection in primed 
WT macrophages decreased rapidly, and by 24 h after chal-
lenge, few infected cells could be detected (Fig. 1 A). In mice, 
acute resistance to T. gondii infection is IGTP dependent (12). 
We therefore tested the ability of primed IGTP-defi  cient 
(IGTP−/−) mice to clear GFP-PTG. As shown in Fig. 1 A, 
the decrease in infection rate in IGTP−/− mice was highly 
  attenuated, resulting in death of GFP-PTG–challenged 
IGTP−/− mice despite priming (Fig. 1 B).
To avoid limitations of the in vivo priming challenge 
model, we infected primed peritoneal exudate cells (PECs) 
ex vivo. Primed WT macrophages still cleared GFP-PTG ef-
fi  ciently ex vivo, whereas IGTP−/− cells failed to do so (Fig. 
1 C). The decrease of GFP positivity determined by fl  ow cy-
tometry refl  ected a reduction of infection rate observed di-
rectly by fl   uorescence microscopy and correlated with 
decreased plaque-forming effi     ciency (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20061318/DC1), 
indicating that primed macrophages eliminate rather than 
simply inhibit T. gondii. The microbicidal activity of primed 
macrophages is clearly IGTP dependent, confi  rmed by data 
(Fig. S3) showing that IGTP acts cell autonomously to eff  ect 
parasite clearance. However, IGTP induction alone is not 
suffi   cient for parasite elimination given that IGTP-expressing 
thioglycollate-elicited macrophages pretreated with IFN-γ 
in vitro were ineff  ectual (Fig. 1 D), suggesting that in vivo 
priming involves additional undefi  ned accessory signals.
Earlier in vitro studies of the anti-Toxoplasma activity of 
macrophages indicated a critical role of inducible nitric oxide 
synthase (iNOS; reference 8). Nevertheless, iNOS-defi  cient 
(iNOS−/−) mice were capable of resisting acute T. gondii in-
fection (13). To clarify the role of iNOS in the IGTP-depen-
dent parasite elimination, we included primed iNOS−/− and 
IGTP−/−iNOS−/− cells in the experiment shown in Fig. 1 E. 
iNOS−/− macrophages cleared the parasites as effi   ciently as 
WT cells, if not better, indicating that iNOS is not required 
for the IGTP-dependent parasite elimination. We can also 
exclude antibody-mediated phagocytosis, as μMt mice also 
cleared the parasite effi   ciently (Fig. S4, available at http://
www.jem.org/cgi/content/full/jem.20061318/DC1).
The nonfusogenic nature of the T. gondii PV was revealed 
using macrophages or other cell types without prior immune 
activation (4, 14). Given that primed macrophages rapidly 
eliminate invaded GFP-PTG, we wondered whether T. gon-
dii can fuse with lysosomes in this system. We probed adher-
ent PECs from primed mice infected with GFP-PTG in vivo 
for LAMP1. At 4 h after infection, a larger percentage of 
GFP-PTG colocalized with LAMP1 staining in primed WT 
than in primed IGTP−/− cells (Fig. 2, A and B, and Videos 
S1 and S2, which are available at http://www.jem.org/cgi/
content/full/jem.20061318/DC1). LAMP1-associated para-
sites appeared to have weakened GFP intensity, probably a 
result of acidifi  cation-induced fl  uorescence quenching (15). 
Using a second method to label lysosomes, adherent PECs 
were pulsed with Texas red–labeled dextran before GFP-
PTG infection ex vivo. We consistently observed higher 
rates of fusion between Texas red–labeled lysosomes and 
GFP-PTG in primed WT macrophages than in IGTP−/− 
cells (Fig. 2, C and D, and Fig. S5). To formally demonstrate 
the role of lysosomal fusion in parasite elimination, we used 
bafi  lomycin A1 to inhibit lysosomal acidifi  cation. Bafi  lomy-
cin A1 treatment attenuated the parasite elimination in 
Figure 1.  IGTP-dependent rapid T. gondii elimination in primed 
macrophages. (A) Impaired T. gondii elimination in primed IGTP−/− mice. 
CPS-primed (day 7 after infection) WT and IGTP−/− mice were challenged 
with 4 × 106 GFP-PTG i.p. Infection rates (mean ± SEM) in peritoneal 
macrophages were determined by FACS (n = 3). (B) Survival of primed 
WT (n = 6) and IGTP−/− (n = 4) mice after GFP-PTG challenge. (C) Infec-
tion rates in primed WT and IGTP−/− peritoneal macrophages after GFP-
PTG infection (MOI of 1, 15 min) ex vivo. Data shown are representative 
of eight experiments. (D) Thioglycolate-elicited WT and IGTP−/− perito-
neal macrophages failed to eliminate T. gondii after GFP-PTG infection 
(MOI of 1, 15 min) when activated in vitro. IFN-γ treatment (1 ng/ml) 
started 12 h before infection. (E) IGTP-dependent rapid T. gondii elimi-
nation in primed macrophages does not require iNOS. Primed (WT, IGTP−/−, 
iNOS−/−, and IGTP−/−iNOS−/−) and naive WT (thioglycolate-elicited) 
PECs were infected with GFP-PTG ex vivo. Data are representative of 
three experiments.JEM VOL. 203, September 4, 2006  2065
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primed WT macrophages (Fig. 2 E), suggesting a role for ly-
sosomal fusion in parasite attrition.
To visualize intracellular events leading to T. gondii de-
struction, we examined the fi  ne structures of the parasites and 
associated host membranes by electron microscopy (EM). 
We pulsed naive and primed macrophages with BSA-gold 
(6 nm) and chased for 3 h to label lysosomes before a 15-min 
pulse infection. 15 nm BSA-gold was present during the in-
fection to distinguish between actively invaded and phagocy-
tosed parasites. Samples were prepared for EM analysis at 1, 
2, and 4 h after infection. Consistent with a nonphagocytic 
mode of entry, shortly after infection, the majority of the 
parasites in both primed WT and IGTP−/− macrophages 
were found within 15 nm of gold-negative PVs associated 
with host ER and mitochondria. We observed a markedly 
higher frequency of parasite degeneration in primed WT 
macrophages than in primed IGTP−/− and naive cells (Fig. 
S6, A–C, available at http://www.jem.org/cgi/content/full/
jem.20061318/DC1). Although heterogeneity in the EM 
profi  les within each sample was noted, contrasting features of 
parasite–host cell interface were clearly observed between 
primed WT and IGTP−/− macrophages. After careful analy-
sis of distinct aberrations in the parasite vacuolar structure 
observed in primed WT  macrophages, here we propose a 
series of events involving PV membrane (PVM) indentation, 
PVM vesiculation/disruption, and parasite plasma membrane 
Figure 2.  Evidence for lysosomal fusion with T. gondii in primed 
macrophages. (A) T. gondii reside in LAMP1+ compartments in primed 
macrophages. Primed mice were challenged with 4 × 106 GFP-PTG i.p. 
Adherent PECs were stained for LAMP1. Green, GFP-PTG; red, LAMP1; 
blue, DAPI. In A and C, arrow heads point to lysosome-associated T. gondii 
with decreased GFP fl  uorescence. (B) Quantifi  cation of fusion events in 
the experiment depicted in A. Percentage of LAMP1+ T. gondii vacuoles 
(mean ± SEM) was determined by counting 20–30 T. gondii–containing 
vacuoles per sample (n = 3 mice per group). (C) T. gondii fuse with dex-
tran-labeled lysosomes in primed macrophages. Green, GFP-PTG; red, 
dextran; blue, DAPI. (D) Quantifi  cation of fusion events in experiments 
depicted in C. Percentage of Texas red–positive T. gondii vacuoles was 
shown (the number above the bar shows the total number of T. gondii–
containing vacuoles counted). (E) Bafi  lomycin A1 (Baf A1) treatment 
(100 nM) attenuated rapid parasite elimination in primed WT macrophages. 
Data are representative of three experiments.2066  HOW DO ACTIVATED MACROPHAGES ELIMINATE TOXOPLASMA? | Ling et al. 
Figure 3.  Ultrastructural alterations of T. gondii PVM and plasma 
membrane in primed WT macrophages. (A) T. gondii PVM indentation 
(phase I) in a primed WT macrophage. (B) Spacious PV in a primed IGTP−/− 
macrophage. (C) Normal PV in a thioglycolate-elicited peritoneal macro-
phage. (D–K) Images of T. gondii in primed WT macrophages. (D–F) PVM 
vesiculation and disruption (phase II). Irregular PVM forms cuplike projec-
tions in D. ER is no longer associated with PVM undergoing vesiculation 
in E. PVM disintegrates into vesicles and tubules radiating away from the 
parasite in F. (G and H) Naked parasites in direct contact with host cytosol 
after PVM dissolution. Note electron-dense T. gondii plasmalemma in H. 
(I and J) Parasite membrane stripping (phase III). Note that the electron-
dense plasmalemma has been severed, exposing the  Inner membrane JEM VOL. 203, September 4, 2006  2067
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stripping (phase I, II, and III, respectively), which ultimately 
lead to lysosomal degradation (phase IV) of the parasite.
Phase I is characterized by the formation of tight-fi  tting 
parasite vacuoles in primed WT macrophages (Fig. 3 A), un-
like the normally spacious T. gondii vacuoles observed in 
primed IGTP−/− (Fig. 3 B) and naive cells (Fig. 3 C). 
Tachyzoites in phase I PVs appeared intact, but little tubulo-
vesicular network formation was observed in the PV lumen. 
PVMs in these tight vacuoles presented an undulating and 
corrugated profi   le, with inward protuberances measuring 
23–60 nm in height, and seemed to closely contact the sur-
face of the parasite more than 10–70% of the circumference 
of the PV (Fig. 3 A and Fig. S7, which is available at http://
www.jem.org/cgi/content/full/jem.20061318/DC1). PVM 
indentation toward the parasite may allow for pathogen rec-
ognition that initiates signals leading to subsequent PVM re-
modeling. Indeed, we obtained multiple images showing 
various degrees of PVM vesiculation, but only in primed WT 
macrophages. In earlier stages of phase II, the previously cor-
rugated PVM presented a jagged and irregular profi  le, with 
subsequent formation of cuplike outward projections of the 
PVM (Fig. 3 D). Initiation of the vesiculation process was as-
sociated with a dispersal of the ER that typically underlies the 
PVM (Fig. 3 E). At later stages of phase II, when extensive 
vesiculation was observed, the PVM disintegrated into vesi-
cles and elongated tubules radiating away from the parasite 
(Fig. 3 F). PVM dissolution resulted in the appearance of 
  naked parasites in direct contact with the host cytosol (Fig. 3 
G). At this stage, the parasite membrane seemed to be intact, 
with a continuous electron-dense plasmalemma and the 
  characteristic double-layered inner cell membrane complex 
(Fig. 3 H). In phase III, detachment of the parasite plasma-
lemma was evident (Fig. 3, I–K). Even more surprisingly, we 
obtained pictures clearly indicating that the parasite outer 
membrane has been severed and folded (Fig. 3, I and J). It 
appeared that the coated plasmalemma stripped from the 
  parasite can form more complex stacks held together by 
  electron-dense bridging structures (Fig. 3 K and Fig. S8).
Phase I, II, and III profi  les in primed WT macrophages 
were frequent at 1 and 2 h after infection, and less so at 
4 h, indicating that PVM disruption and parasite denuda-
tion happens early and proceeds rapidly. Overall, the above 
events were rarely observed in naive macrophages and 
primed IGTP−/− cells. Of more than 100 T. gondii sections 
examined in primed IGTP−/− macrophages, we found 
only one phase III–denuded parasite (vs. 15–20% in primed 
WT cells), suggesting that IGTP could play an active role 
in the denudation process. However, the machinery that 
mediates plasmalemma severing and stripping in phase III 
remains enigmatic.
Our ultrastructural analysis of the fate of T. gondii within 
primed macrophages provides a clear picture of how an ac-
tivated macrophage aggressively disrupts the intracellular 
niche, which the parasite attempts but fails to establish. In a 
study of T. gondii infection of in vitro IFN-γ–activated as-
trocytes, Martens et al. (16) recently reported similar vesicu-
lation and disruption of the PVM. However, how the 
parasite was eventually eliminated remained unclear be-
cause, unlike our results obtained in primed macrophages, 
no evidence for lysosomal fusion with T. gondii was ob-
served in astrocytes.
We considered autophagy as the likely mechanism lead-
ing to the lysosomal destruction of the denuded parasites dur-
ing phase IV. Although autophagy is normally considered a 
homeostatic cellular response to stress and starvation (17), re-
cent reports have documented an emerging link between au-
tophagy and antimicrobial defense (18–20). To probe the 
involvement of autophagy, we used inhibitors of PI3K func-
tion, which is required for autophagosome formation (21). 
As shown in Fig. 4 A, the addition of three distinct PI3K 
  inhibitors (wortmannin, LY294002, and 3-methyladenine) 
uniformly attenuated IGTP-dependent parasite elimination 
in primed eff  ector cells, suggesting the involvement of an au-
tophagy-like response against the parasite. Autophagic vacu-
oles are characteristically double membrane structures, which 
retain the fl   uorescent dye, monodansylcadaverine (MDC; 
reference 22). Indeed, we found extensive colocalization of 
GFP-PTG with MDC in primed WT macrophages and to a 
lesser extent in primed IGTP−/− cells (Fig. 4 B). Defi  nitive 
evidence indicating autophagosome formation is provided by 
the EM images shown in Fig. 4 (C and D) and Fig. S9 (A–C), 
which is available at http://www.jem.org/cgi/content/full/
jem.20061318/DC1. Multiple autophagosome-like vacuoles 
surrounding entire parasites together with associated host 
  cytosolic material were found in primed WT macrophages. 
Autophagosomes contained only parasites with disrupted 
plasma membrane, suggesting that leakage of internal anti-
gens of the parasite may provide signals for autophagy induc-
tion. Fusion of fl  attened elongated vesicles appeared to give 
rise to double membrane structures characteristic of autopha-
gosomes (Fig. 4 E; reference 23), which can ultimately fuse 
with lysosomes. Indeed, consistent with Fig. 2, we observed 
fusion of BSA-gold–labeled lysosomes with Toxoplasma-con-
taining autophagic vacuoles (Fig. 4, F and G, and Fig. S10), 
indicating the involvement of an autophagic mechanism that 
leads to lysosome-mediated destruction of the parasite. Esti-
mation of the rate of lysosomal fusion with parasite-contain-
ing vacuoles using BSA-gold labeling showed that IGTP 
defi  ciency decreased the frequency of such events by  2–10-
fold (Fig. 4 H).
complex to host cytosol. Severed plasmalemma can fold onto itself, form-
ing membrane double layers or whorls (J). (K) Detached parasite plasma 
membrane forming complex stacks. Note layers of detached plasma-
lemma held together by electron-dense bridging structures magnifi  ed in 
inset. T.g., T. gondii; black arrows, PVM; white arrows, PV-associated ER; 
black arrow heads, T. gondii plasma membrane; white arrow heads, 
T. gondii inner membrane complex; bars, 500 nm.2068  HOW DO ACTIVATED MACROPHAGES ELIMINATE TOXOPLASMA? | Ling et al. 
The pleitropic eff  ect of IGTP defi  ciency on the killing 
activity of primed macrophages raises the question of when 
IGTP participates in the steps of PVM indentation, vesicula-
tion and disruption, and parasite plasma membrane stripping. 
The p47 GTPase, IIGP, has been localized by immunofl  uo-
rescence microscopy to the PV in astrocytes (16), but whether 
IGTP is also found in the PV remains controversial (24). We 
therefore performed cryo- immunoelectron microscopy to 
visualize IGTP localization within primed and T. gondii–
  infected WT macrophages. Using IGTP-defi  cient  macro-
phages as negative controls, clustered IGTP-specifi  c labeling 
adjacent to the parasite was observed (Fig. 5 A), showing 
that IGTP is positioned to take part in some of the above-
mentioned membrane-disruptive events. Strikingly, IGTP 
immunostaining was also focally associated with autophago-
some-like structures containing denuded T. gondii (Fig. 5 B), 
suggesting IGTP’s role in autophagosome formation or 
  maintenance (25).
Unlike Mycobacteria and Salmonella, which establish vacu-
olar niches along the endo-lysosomal route,  apicomplexan 
parasites present special challenges to eff  ector cells in their 
apparent seclusion from lysosome fusion. The series of events 
Figure 4.  Autophagic elimination of T. gondii in primed macro-
phages. (A) PI3K inhibitors (100 nM wortmannin, 100 μM LY294002, and 
10 mM 3-MA 30 min before and after GFP-PTG infection) attenuated 
rapid parasite elimination in primed WT macrophages. (B) Colocalization 
of GFP-PTG (green) with MDC (blue) staining in primed WT macrophages 
at 2 h after infection. (C and D) Autophagosome formation in primed WT 
macrophages. Arrows point to the autophagosome outer membrane. Note 
the space between the outer and inner membranes and the denuded 
T. gondii with part of host cytoplasm (Cyt) within autophagosomes. 
(D) Autophagosome formation around a partially denuded parasite. 
Note detachment and folding of the electron-dense plasmalemma (arrow 
heads). (E) Fusion of fl  attened vesicles (arrows) giving rise to double 
membrane autophagosomes. (F) Fusion of lysosomes with T. gondii–
  containing autophagic vacuoles. Arrows point to lysosomes containing 
6-nm gold particles. (G) High magnifi  cation of the fusion event shown in F. 
(H) EM quantifi  cation of lysosomal fusion with T. gondii. (I) Proposed 
phases of T. gondii elimination in primed macrophages. Black, T. gondii 
plasmalemma; gray, T. gondii inner membrane complex; blue, PVM; ma-
genta, ER; green, autophagosome inner membrane; red, autophagosome 
outer membrane; gray vesicles, lysosomes; bars, 500 nm.JEM VOL. 203, September 4, 2006  2069
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Figure 5.  Localization of IGTP in T. gondii–infected primed WT 
macrophages. (A) IGTP immunoreactivity (15-nm gold, highlighted by 
arrows) in clusters adjacent to parasite (T. gondii). (B) IGTP immunoreac-
tivity (highlighted by arrows) associated with the periphery of an au-
tophagosome-like profi  le, with the characteristic circumferential 
clearance around the denuded parasite (T. gondii). Arrow head pinpoints 
stripped parasite plasmalemma, similar to one shown in Fig. 4 C.
we have described here outline a previously unrecognized 
and mechanistically distinct solution to the problem posed by 
nonfusogenic intracellular pathogens (Fig. 4 I). It remains un-
clear why autophagosome formation around T. gondii and 
lysosome fusion with the parasite were not observed in resid-
ual parasites after PVM disruption in astrocytes (16). This dis-
parity may arise simply from methodological diff  erences (in 
vitro activation of cultured astrocytes vs. in vivo priming of 
infl  ammatory macrophages) or may be a true refl  ection of in-
nate diff  erences in the defense arsenal of parenchymal (astro-
cyte) versus professional eff   ector cells (macrophages). A 
related question yet to be resolved is whether the autopha-
golysosomal degradation of denuded T. gondii (phase IV) is 
the direct cause of parasite demise or it simply represents a 
cell-type–restricted cytosolic response to clear T. gondii rem-
nants after parasite killing in the preceding steps (phase I, II, 
or III). It will be interesting to fi  nd out whether other api-
complexan parasites such as Cryptosporidum, Eimeria, and Plas-
modium are subject to the same series of PVM disruption and 
pathogen membrane denudation reactions after invasion of 
immune-activated intestinal and hepatic cells, respectively. 
Another important question is whether human cells can exe-
cute the same aggressive parasite elimination strategies described 
here using compensatory mechanisms given the apparent loss 
of the entire family of IFN-γ–responsive p47 GTPases genes 
during primate evolution (26).
MATERIALS AND METHODS
Experimental animals
C57BL/6, iNOS−/−, Sjl (CD45 congenic), and μMt mice were obtained 
from The Jackson Laboratory. These mice, along with IGTP−/− and 
IGTP−/−NOS−/− mice, were bred and maintained under specifi  c pathogen-
free conditions at the Brown University animal care facility. Mice of both 
sexes between 5 and 12 wk old were used for experiments. Studies were 
performed in accordance with guidelines of the Brown University Institu-
tional Animal Care and Use Committee.
Parasites
The uracil auxotrophic CPS strain of T. gondii was provided by D. Bzik 
(Dartmouth Medical School, Hanover, NH; reference 10). GFP-PTG was 
obtained from American Type Culture Collection (no. 50941; reference 27). 
CPS parasites were γ irradiated at 15,000 rads before use. In some experi-
ments, fresh parasites fi  xed with 3% paraformaldehyde were used.
In vivo priming
For priming, 106 irradiated CPS were injected i.p. At day 4 after initial 
injection, another dosage of the same parasites (105, i.p.) was introduced to 
boost the priming eff  ect. Primed mice were used on day 7.
In vivo infection and survival
GFP-PTG resuspended in PBS was injected into the peritoneal cavity of 
primed mice. At diff  erent time points after infection, PECs were harvested 
by lavaging with RPMI medium containing 5% FBS (Hyclone). Flow cy-
tometry was used to monitor the infection rate in PECs. In survival experi-
ments, primed WT and IGTP−/− mice were challenged with 2.5 × 105 
GFP-PTG and mice were monitored daily.
Ex vivo infection and treatments
PECs from primed or thioglycolate-injected mice were mixed with GFP-PTG 
in 1–2 ml of invasion medium (DMEM with 1% FBS, multiplicity of infection 
[MOI] of 0.5–1) in 15-ml conical tubes for 15–30 min at 37°C. To terminate 
infection, cold RPMI with 5% FBS was added to fi  ll the tubes. Free parasites 
were removed by diff  erential centrifugation. Infected PECs were resuspended 
in RPMI with 10% FBS and aliquoted for assays at diff  erent time points.
In some experiments, PECs from primed Sjl (CD45.1+) and IGTP−/− 
(CD45.2+) were mixed together before GFP-PTG infection (MOI of 1, 15 
min) ex vivo. Surface staining for CD45.1 and CD45.2 antigen was used to 
diff  erentiate the two cell populations by fl  ow cytometry.
IFN-𝗄 treatment. In experiments where activation of thioglycolate-elic-
ited peritoneal macrophages in vitro was desired, IFN-γ (1 ng/ml)   
treatment started 12 h before infection and was maintained after infection.
Bafi  lomycin-A1 treatment. To inhibit lysosome function, PECs were 
pretreated with 100 nM bafi  lomycin-A1 for 1 h. After infection with 2070  HOW DO ACTIVATED MACROPHAGES ELIMINATE TOXOPLASMA? | Ling et al. 
GFP-PTG, bafi  lomycin-A1 was resupplied and maintained throughout 
the experiment.
PI3K inhibition. 100 nM wortmannin, 100 μM LY294002, and 10 mM 
3-methyladenine were used to inhibit PI3K activity. PI3k inhibitor treat-
ment started 30 min before infection and was maintained after infection. All 
PECs were maintained and all reagents were diluted in RPMI with 10% FBS 
unless otherwise stated.
Flow cytometry
PECs were fi  xed with CytoFix (BD Biosciences) before analysis. GFP posi-
tivity detected by fl  ow cytometry (FACSCalibur; Becton Dickinson) was 
used to determine the infection rate in PECs. Shown in this study are infec-
tion rates in macrophages, defi  ned as being forward scatterhigh and side scat-
terhigh. These large, granular cells were >90% CD11b+F4/80+, as determined 
in a separate experiment with surface staining for CD 11b (BD Biosci-
ences) and F4/80 (eBioscience) antigens.
Parasite viability assay
The viability of T. gondii residing in host cells at diff  erent time points after 
infection was determined by plaque assay. In brief, a small volume (0.5 ml) 
of infected PEC suspension was passed through a 27-gauge needle 10 times 
to liberate the parasites. The needle-passaged lysates (volume adjusted to en-
sure equal plating) were plated onto human foreskin fi  broblast monolayers in 
24-well plates. 6 d after plating, the number of plaques was counted and the 
change (relative to time 0) in plaque-forming effi   ciency was calculated.
Fluorescent staining and microscopy
LAMP1 staining. PECs infected with GFP-PTG in vivo were seeded onto 
FBS-coated coverslips in 24-well plates for 2 h and washed with PBS before 
being prepared for LAMP1 staining. For ex vivo infection, PECs were al-
lowed to adhere onto coverslips for 3 h, and nonadherent cells were washed 
away with PBS. After a 10-min incubation with GFP-PTG in invasion me-
dium at 37°C, adherent PECs were washed extensively with PBS to remove 
extracellular parasites. Infected cells were incubated in RPMI with 10% me-
dium at 37°C until being processed at diff  erent time points for immunofl  uo-
rescent staining.
Adherent PECs were washed with PBS twice before fi  xation with 3% 
paraformaldehyde for 15 min at room temperature. After permeabilization 
(0.1% Triton X-100 in PBS for 10 min) and blocking (5% goat serum, 1% 
BSA, 0.05% Tween20 in PBS for 1 h), cells were incubated with LAMP1 
antibody (1D4B; 0.335 ug/ml, diluted in blocking buff  er; DSHB, University 
of Iowa) for 45 min. Rat IgG was included as negative control. After wash-
ing, cells were further incubated with Alexa Fluor 568–conjugated goat anti–
rat antibody (1:1,000, diluted in blocking buff  er; Invitrogen) for 30 min, 
followed by washing and DAPI staining. Stained coverslips were mounted 
onto slides with ProLong antifade (Invitrogen) and sealed with nail polish.
IGTP staining. PECs from day 7 primed mice were harvested and allowed 
to adhere onto coverslips for 4 h before being fi  xed and stained according to 
the similar procedure described above. 1 ug/ml monoclonal anti-IGTP anti-
body (BD Biosciences) conjugated with Alexa Fluor 647 (Invitrogen) was 
used for staining.
Lysosome labeling with Texas red dextran. Adherent PECs were 
pulsed with lysine-fi  xable dextran Texas red (0.5 mg/ml, 10 kD; Invitrogen) 
for 1 h. After washing and 3 h of incubation, dextran was chased into lyso-
somes before GFP-PTG infection (28).
MDC staining. At 2 h after GFP-PTG infection, adherent PECs were in-
cubated with MDC (0.05 mM in PBS; Sigma-Aldrich) for 10 min. After 
three washes, cells were left in PBS and immediately photographed.
Fluorescent photomicrographs were acquired using a Zeiss Axiovert 
200M microscope. Confocal images were acquired using a Leica TCS SP2 
AOBS spectral confocal microscope.
EM
Before GFP-PTG infection, naive and primed macrophages were pulsed 
with 6 nm BSA-gold and incubated for 3 h to chase this label into lysosomes. 
15 nm BSA-gold was present during the 15-min pulse infection to distin-
guish between actively invaded and phagocytosed T. gondii parasites. Sam-
ples were prepared for transmission EM analysis at 1, 2, and 4 h after infection 
as described previously (29). For immunoelectron microscopy, cells were 
fi  xed in 4% paraformaldehyde (Electron Microscopy Sciences) in 0.25 M 
Hepes, ph 7.4, for 1 h at room temperature, and then in 8% paraformalde-
hyde in the same buff  er overnight at 4°C (30). They were infi  ltrated, frozen, 
and sectioned as previously described (30). The sections were immunola-
beled with anti-IGTP antibody (1:20 in PBS/1% fi  sh skin gelatin), and then 
with anti–mouse IgG antibodies, followed directly by 15 nm of protein A–
gold particles (Department of Cell Biology, Medical School, Utrecht Uni-
versity) before examination with a Philips CM120 electron microscope 
(Eindhoven) under 80 kV.
Online supplemental material
Fig. S1 shows the scheme for the CPS-priming GFP-PTG challenge experi-
mental system. Fig. S2 shows the plaque assay determination of T. gondii 
  viability after ex vivo infection of peritoneal cells. Fig. S3 shows the cell-
  autonomous eff  ect of IGTP on parasite clearance by primed PECs. Fig. S4 
demonstrates that rapid parasite elimination does not require B cells and Ig. 
Confocal photomicrographs of dextran-labeled macrophages infected with 
GFP-PTG are shown in Fig. S5. Fig. S6 shows electron micrographs of para-
site degeneration in primed WT, but not in IGTP knockout, macrophages. 
Fig. S7 shows PVM indentation in a primed WT macrophage. Fig. S8 shows 
that the detached parasite plasma membrane can form complex stacks. Fig. S9 
shows additional examples of autophagosomes containing denuded parasites. 
Fig. S10 is an electron micrograph of T. gondii remnants within autophagoly-
sosomes containing fl  occulated 15-nm gold particles used in this experiment 
to trace lysosomes.  Supplementary videos of stacked images (Videos S1 
and S2) are also provided. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20061318/DC1.
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